Condition Focus: Lymphatic Drainage — Systemic Waste Clearance Principle
The glymphatic system — the brain’s waste clearance network — was discovered relatively recently and has become a major research focus. This review from Salehpour and colleagues in the International Journal of Molecular Sciences examines how PBM augments glymphatic function, enhancing the clearance of metabolic waste products through lymphatic drainage pathways.
While the review focuses on brain lymphatics (clearing amyloid beta and tau proteins implicated in neurodegeneration), the underlying principle is universal: PBM enhances the body’s lymphatic clearance systems. The mechanisms identified — stimulation of meningeal lymphatic vessels, modulation of AQP4 (aquaporin-4) water channels that facilitate fluid flow, and enhanced waste metabolite drainage — are variations of the same fluid dynamics and cellular signalling pathways that operate in peripheral lymphatic vessels around joints.
For gout, the clearance principle is the relevant takeaway. The gouty joint accumulates urate crystals, inflammatory cytokines, dead immune cells, and damaged tissue debris. The lymphatic system is the primary route for removing these materials from the joint space. Evidence that PBM augments lymphatic drainage capacity — in any tissue — supports the rationale for using PBM to enhance joint clearance in gout.
The review also discusses how PBM may enhance macrophage phagocytic activity within the lymphatic system, potentially improving the uptake and processing of particulate waste. In gout, the particulate waste includes urate microcrystals — the very particles that must be cleared to prevent future flares.
G.O.A.T. for Gout Alignment:
The waste clearance principle demonstrated here — PBM enhances lymphatic drainage and waste removal — applies to the G.O.A.T.’s target joint. By combining vascular perfusion improvement (NO pathway) with lymphatic drainage enhancement, the G.O.A.T. supports both sides of the fluid equation: nutrients in, waste out.
Link to original research here
Editor’s note: The direct lymphatic vessel contractility evidence is provided by PBM Lymphatic Contractility 2020. The clinical lymphedema evidence confirming volume reduction in humans is in Lymphedema Systematic Review 2022. The vascular perfusion that complements lymphatic drainage is demonstrated in Gavish et al 2020. The NO-mediated vasodilation mechanism is reviewed in Keszler et al 2023.
Related Articles
- PBM Stimulates Lymphatic Contractility and Flow – 2020
- PBM for Lymphedema: Systematic Review of RCTs – 2022
- Microcirculatory Response to PBM: RCT – Gavish et al 2020
- PBM and Nitric Oxide Signaling – Keszler et al 2023
- PBM on RA and OA: Edema and Vascular Permeability – Fonseca et al 2025
Key Takeaways
- PBM enhances lymphatic drainage and waste metabolite clearance — demonstrated in glymphatic system
- Principle applies to peripheral lymphatics: clearing urate, cytokines, and cell debris from gouty joints
- AQP4 modulation and meningeal lymphatic stimulation — fluid dynamics mechanisms
- Enhanced macrophage phagocytic activity may improve clearance of urate microcrystals
Study Overview
| Study Type: | Review |
| Wavelength(s): | Red + NIR |
| Treatment Protocol: | Varies across reviewed studies |
| Sample Size: | Review of glymphatic and lymphatic drainage studies |
| Primary Outcome: | Enhanced lymphatic drainage, AQP4 modulation, waste clearance↑ |
Full Citation
Salehpour F, et al. (2022). Photobiomodulation and the glymphatic system: augmenting the brain’s lymphatic drainage. International Journal of Molecular Sciences, 23(6), 3203. View Publication
